Literature DB >> 26320341

[Algorithm for treating preoperative anemia].

E Bisbe Vives1, M Basora Macaya2.   

Abstract

Hemoglobin optimization and treatment of preoperative anemia in surgery with a moderate to high risk of surgical bleeding reduces the rate of transfusions and improves hemoglobin levels at discharge and can also improve postoperative outcomes. To this end, we need to schedule preoperative visits sufficiently in advance to treat the anemia. The treatment algorithm we propose comes with a simple checklist to determine whether we should refer the patient to a specialist or if we can treat the patient during the same visit. With the blood count test and additional tests for iron metabolism, inflammation parameter and glomerular filtration rate, we can decide whether to start the treatment with intravenous iron alone or erythropoietin with or without iron. With significant anemia, a visit after 15 days might be necessary to observe the response and supplement the treatment if required. The hemoglobin objective will depend on the type of surgery and the patient's characteristics.
Copyright © 2015 Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Anemia preoperatoria; Cirugía; Eritropoyetina; Erythropoietin; Hemoglobin; Hemoglobina; Hierro intravenoso; Intravenous iron; Perioperative anemia; Surgery

Mesh:

Substances:

Year:  2015        PMID: 26320341     DOI: 10.1016/S0034-9356(15)30004-9

Source DB:  PubMed          Journal:  Rev Esp Anestesiol Reanim        ISSN: 0034-9356


  2 in total

Review 1.  Peri-operative treatment of anaemia in major orthopaedic surgery: a practical approach from Spain.

Authors:  Elvira Bisbe; Misericordia Basora; María J Colomina
Journal:  Blood Transfus       Date:  2017-01-26       Impact factor: 3.443

2.  Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia.

Authors:  José Luis Calleja; Salvadora Delgado; Adolfo del Val; Antonio Hervás; José Luis Larraona; Álvaro Terán; Mercedes Cucala; Fermín Mearin
Journal:  Int J Colorectal Dis       Date:  2015-12-22       Impact factor: 2.571

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.